[1] LORENTZONAND M, CUMMINGS SR. Osteoporosis: the evolution of a diagnosis. J Intern Med. 2015;277(6): 650-661.
[2] RAISZAND LG, PRESTWOOD KM. Epidemiology and pathogenesis of osteoporosis. Clin Cornerstone. 2000;2(6):1-10.
[3] 国家卫生健康委员会官网.国家卫生健康委发布首个中国骨质疏松症症流行病学调查结果[J].人口文摘,2018(11): 55-56.
[4] HUANG J, YE Y, XIAO Y, et al. Geniposide ameliorates glucocorticoid-induced osteoblast apoptosis by activating autophagy. Biomed Pharmacother. 2022;155:113829.
[5] HAN D, GU X, GAO J, et al. Chlorogenic acid promotes the Nrf2/HO-1 anti-oxidative pathway by activating p21(Waf1/Cip1) to resist dexamethasone-induced apoptosis in osteoblastic cells. Free Radic Biol Med. 2019;137:1-12.
[6] IBANEZ L, FERRANDIZ ML, BRINES R, et al. Effects of Nrf2 deficiency on bone microarchitecture in an experimental model of osteoporosis. Oxid Med Cell Longev. 2014;2014:726590.
[7] LOBODA A, DAMULEWICZ M, PYZA E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221-3247.
[8] WEIVODA MM, CHEW CK, MONROE DG, et al. Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism. Nature Communications. 2020;11(1):87.
[9] JOBKE B, MILOVANOVIC P, AMLINGAND M, et al. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients. Bone. 2014;59:37-43.
[10] OTTO S, ABU-ID MH, FEDELE S, et al. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study. J Craniomaxillofac Surg. 2011;39(4):272-277.
[11] YAMAGUCHI M. Role of carotenoid beta-cryptoxanthin in bone homeostasis. J Biomed Sci. 2012;19(1):36.
[12] RAOAND AV, AGARWAL S. Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr. 2000;19(5):563-569.
[13] AGARWALAND S, RAO AV. Tomato lycopene and its role in human health and chronic diseases. CMAJ. 2000;163(6):739-744.
[14] FUJII H, NODA T, SAIRENCHIAND T, et al. Daily intake of green and yellow vegetables is effective for maintaining bone mass in young women. Tohoku J Exp Med. 2009;218(2): 149-154.
[15] YANG Z, ZHANG Z, PENNISTON KL, et al. Serum carotenoid concentrations in postmenopausal women from the United States with and without osteoporosis. Int J Vitam Nutr Res. 2008;78(3):105-111.
[16] CHENG D, ZHANG Y, LIU H, et al. An improving method for extracting total carotenoids in an aquatic animal Chlamys nobilis. Food Chem. 2019;280:45-50.
[17] WANG S, WU S, YANG G, et al. A review on the progress, challenges and prospects in commercializing microalgal fucoxanthin. Biotechnol Adv. 2021;53:107865.
[18] LOURENCO-LOPES C, FRAGA-CORRAL M, JIMENEZ-LOPEZ C, et al. Biological action mechanisms of fucoxanthin extracted from algae for application in food and cosmetic industries. Trends Food Sci Technol. 2021;117:163-181.
[19] DAS SK, REN R, HASHIMOTOAND T, et al. Fucoxanthin induces apoptosis in osteoclast-like cells differentiated from RAW264.7 cells. J Agric Food Chem. 2010;58(10):6090-6095.
[20] HA YJ, CHOI YS, OH YR, et al. Fucoxanthin Suppresses Osteoclastogenesis via Modulation of MAP Kinase and Nrf2 Signaling. Mar Drugs. 2021;19(3):132.
[21] KOSE O, ARABACI T, YEMENOGLU H, et al. Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. Mar Drugs. 2016;14(4):70.
[22] OLAGNIER D, FARAHANI E, THYRSTED J, et al. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate (vol 11, 4938, 2020). Nat Commun. 2020;11(1):4938.
[23] CHANDLER H, BROOKS DJ, HATTERSLEY G, et al. Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia. Osteoporos Int. 2019;30(8):1607-1616.
[24] YANG YS, XIE J, WANG D, et al. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat Commun. 2019;10(1):2958.
[25] BORUMANDI F, AGHALOO T, CASCARINI L, et al. Anti-resorptive Drugs and their Impact on Maxillofacial Bone among Cancer Patients. Anticancer Agents Med Chem. 2015;15(6):736-743.
[26] JIANG M, LIU R, LIU L, et al. Identification of osteogenic progenitor cell-targeted peptides that augment bone formation. Nat Commun. 2020;11(1):4278.
[27] REIDAND IR, BILLINGTON EO. Drug therapy for osteoporosis in older adults. Lancet. 2022;399(10329):1080-1092.
[28] SAAG KG, PETERSEN J, BRANDI ML, et al. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis. N Engl J Med. 2017;377(15):1417-1427.
[29] LANGDAHL BL, HOFBAUERAND LC, FORFAR JC. Cardiovascular Safety and Sclerostin Inhibition. J Clin Endocrinol Metab. 2021;106(7):1845-1853.
[30] DE CASTRO LF, MICHEL Z, PAN K, et al. Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone. N Engl J Med. 2023;388(8):766-768.
[31] MERESSE S, FODIL M, FLEURYAND F, et al. Fucoxanthin, a Marine-Derived Carotenoid from Brown Seaweeds and Microalgae: A Promising Bioactive Compound for Cancer Therapy. Int J Mol Sci. 2020;21(23):9273.
[32] GAMMONEAND MA, D’ORAZIO N. Anti-obesity activity of the marine carotenoid fucoxanthin. Mar Drugs. 2015;13(4):2196-2214.
[33] LIU M, LI W, CHEN Y, et al. Fucoxanthin: A promising compound for human inflammation-related diseases. Life Sci. 2020;255:117850.
[34] KOYAMA T. Extracts of marine algae show inhibitory activity against osteoclast differentiation. Adv Food Nutr Res. 2011;64:443-454.
[35] WALSH PJ, MCGRATH S, MCKELVEY S, et al. The Osteogenic Potential of Brown Seaweed Extracts. Mar Drugs. 2019;17(3):141.
[36] JOSHI A, IYENGAR R, JOO JH, et al. Nuclear ULK1 promotes cell death in response to oxidative stress through PARP1. Cell Death Differ. 2016;23(2):216-230.
[37] SCHLUTER KS, WOLF A, WEBER M, et al. Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way. Basic Res Cardiol. 2017;112(6):63.
[38] SEBASTIAN S, ZHU YX, BRAGGIO E, et al. Multiple myeloma cells’ capacity to decompose H(2)O(2) determines lenalidomide sensitivity. Blood. 2017;129(8):991-1007.
[39] CHENG KY, GUO F, LU JQ, et al. MnTM-4-PyP modulates endogenous antioxidant responses and protects primary cortical neurons against oxidative stress. CNS Neurosci Ther. 2015;21(5):435-445.
[40] DENG S, DAI G, CHEN S, et al. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3beta signaling pathway. Biomed Pharmacother. 2019;110:602-608.
[41] LIU X, LIN X, ZHANG S, et al. Lycopene ameliorates oxidative stress in the aging chicken ovary via activation of Nrf2/HO-1 pathway. Aging (Albany NY). 2018;10(8):2016-2036.
[42] NITURE SK, KHATRIAND R, JAISWAL AK. Regulation of Nrf2-an update. Free Radic Biol Med. 2014;66:36-44.
[43] KOKOT A, METZE D, MOUCHET N, et al. Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin. Endocrinology. 2009;150(7):3197-3206.
[44] WANG Y, WU H, XIN Y, et al. Sulforaphane Prevents Angiotensin II-Induced Testicular Cell Death via Activation of NRF2. Oxid Med Cell Longev. 2017;2017:5374897.
[45] CHEN X, ZHU X, WEI A, et al. Nrf2 epigenetic derepression induced by running exercise protects against osteoporosis. Bone Res. 2021;9(1):15.
[46] XU P, LIN B, DENG X, et al. VDR activation attenuates osteoblastic ferroptosis and senescence by stimulating the Nrf2/GPX4 pathway in age-related osteoporosis. Free Radic Biol Med. 2022;193(Pt 2):720-735.
[47] GUO J, REN R, GUO Z, et al. Probucol suppresses osteoclastogenesis via activating Nrf2 signaling and ameliorates ovariectomy-induced bone loss. Int Immunopharmacol. 2023;116:109820.
[48] MORATILLA-RIVERA I, SANCHEZ M, VALDES-GONZALEZAND JA, et al. Natural Products as Modulators of Nrf2 Signaling Pathway in Neuroprotection. Int J Mol Sci. 2023;24(4):3748.
|